NS · Pharmaceuticals

Neuland Laboratories Ltd (NEULANDLAB)

Pharmaceuticals & Biotechnology

Neuland Laboratories Ltd (NEULANDLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $232.23B, P/E ratio is 63.96, net margin is 18.0%, dividend yield is 0.19%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NEULANDLAB

Market cap

$232.23B

P/E ratio

63.96

Net margin

18.0%

Dividend yield

0.19%

Neuland Laboratories Ltd (NEULANDLAB) — FAQ

What is Neuland Laboratories Ltd's market cap?

Neuland Laboratories Ltd (NEULANDLAB) has a reported market cap of $232.23B (data as of 2026-07-10).

What is NEULANDLAB's P/E ratio?

The price-to-earnings (P/E) ratio for Neuland Laboratories Ltd (NEULANDLAB) is 63.96 (data as of 2026-07-10).

Does Neuland Laboratories Ltd pay a dividend?

Neuland Laboratories Ltd (NEULANDLAB) shows a reported dividend yield of 0.19%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Neuland Laboratories Ltd in?

Neuland Laboratories Ltd (NEULANDLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is NEULANDLAB listed on?

NEULANDLAB is listed on NS.

What is Neuland Laboratories Ltd's net margin?

Neuland Laboratories Ltd (NEULANDLAB) reports a net margin of 18.0% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)